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Context:Themajorhealth threats causedby vitaminDdeficiency in the younggenerationhavenot
been fully elucidated.
Objective: The aim of this study was to investigate skeletal and nonskeletal effects of vitamin D
deficiencyand to study theoptimal level of serum25-hydroxyvitaminD [25(OH)D] in youngpeople.
Design and Setting: The Fourth Korea National Health and Nutrition Examination Surveys
(KNHANES IV) was conducted in 2008–2009.
Participants:Atotal of 4276people (1926menand2350women)aged10–40yrwere selected from
16 administrative districts of South Korea.
Main Outcome Measures: We measured age-specific changes in bone mineral density (BMD) ac-
cording to serum 25(OH)D.
Results: Serum 25(OH)D was less than 25 nmol/liter in 18.8% of participants, 25 to less than 50
nmol/liter in 50.0%, 50 to less than 75 nmol/liter in 27.0%, and 75 nmol/liter or greater in 4.2%.
Vitamin D deficiency wasmore frequent in women than inmen. There were gender differences in
the skeletal effects of vitaminDdeficiency. Inmenbetween10 and22 yr old, BMDwas significantly
higher in thevitaminD-sufficientgroup,and inmenbetween23and40yrold,apositivecorrelation
betweenserum25(OH)DandBMDwasobserved.However, inwomen,wecouldnot find significant
differences in BMDaccording to vitaminD status. VitaminDdeficiency in younger generations had
no remarkable effects on most nonskeletal parameters or on the prevalence of concomitant dis-
eases except for rheumatoid arthritis.
Conclusions: Vitamin D plays an essential role in skeletal health of young people. Moreover, the
presence of gender-dependent skeletal effects was an important observation of this study. Reas-
surance of serum25(OH)Dup to 20–30ng/ml or higher is necessary, especially during themodeling
phase in men. (J Clin Endocrinol Metab 97: 1995–2004, 2012)
Recent epidemiological studies have suggested that vi-tamin D deficiency is prevalent in all age groups and
has become amajor health concern (1).However, the sup-
ply of vitamin D from dietary sources is limited, and bio-
chemical synthesis of vitamin D from sunlight exposure is
no longer adequate due to changing lifestyles and concerns
for skin cancer (2, 3). Therefore, fortification of daily food
products or vitamin D supplements should be considered
around the world.
Maximizing peak bone mass (PBM) in childhood
should offer protection against bone loss later in life,
which may lead to osteoporosis. This bone loss is charac-
terized by compromised bone strength and increases in the
likelihood of fractures, which are serious health problems
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in the elderly. It has been estimated that a 10% increase in
peak bonemineral density (BMD) could delay the onset of
osteoporosis by 13 yr (4). Themajor determinants of PBM
include genetic factors, gender, endocrine status (such as
sex hormones, GH, and IGF-I), calcium intake, exercise,
and so on (5). After reaching PBM, bone mass gradually
decreases inmen,whereas it ismaintained until perimeno-
pausal age in women. Recently, we reported that vitamin
D deficiency is a greater threat to the younger generation
in Korea; in 65.0% of men and 79.9% of women aged
20–29 yr, serum 25-hydroxyvitamin D [25(OH)D] was
less than 20 ng/ml (6). However, few studies have evalu-
ated the major health threats caused by vitamin D defi-
ciency in the youth or the differences in skeletal and non-
skeletal health across different age groups.
The optimal level of serum 25(OH)D is still heavily
debated. The Institute ofMedicine (IOM) reports stressed
that a serum 25(OH)D level of 20 ng/ml is sufficient to
ensure bone health, but the results for nonskeletal benefits
are inconclusive (7). The impact of recent reports on the
DietaryReference Intakes for calciumand vitaminD from
the IOM led physicians to decrease their vitamin D rec-
ommendations to patients. Contrary to IOM recommen-
dations, The Endocrine Society released new guidelines in
2011 to treat vitamin D deficiency. The key points from
The Endocrine Society’s clinical guidelines are that a min-
imum serum 25(OH)D level of 30 ng/ml (rather than 20
ng/ml) is recommended and to guarantee sufficiency be-
tween 40 and 60 ng/ml for both children and adults (2).
Some experts insist that the Recommended Daily Allow-
ance, by definition, shouldmeet the needs of 97.5%of the
population, and a skeletal need at higher levels should be
fulfilled.
Therefore, we hypothesized that vitamin D plays an
essential role in skeletal and nonskeletal health in young
people. To better understand the optimal level of serum
25(OH)D, we analyzed BMD, geometric indices, bio-
chemical parameters,metabolic profiles includinghomeo-
staticmodel assessment of insulin resistance (HOMA-IR),
and associated diseases. We found a gender difference in
the skeletal effects of vitamin D deficiency. Moreover, al-
though the correlation coefficient was low, there was a
positive relationship between serum 25(OH)D and BMD.
Also, small additional benefits of BMD greater than 30
ng/ml were found only in males aged 10–22 yr old.
Subjects and Methods
Study participants
This study was based on data acquired from the second
(2008) and third years (2009) of the Fourth Korea National
Health and Nutrition Examination Surveys (KNHANES IV),
which was conducted from July 2007 to December 2009. The
KNHANESwas a cross-sectional andnational survey conducted
by the Division of Chronic Disease Surveillance, Korea Centers
forDiseaseControl andPrevention, starting in1998.This survey
was composed of a health interview survey, a nutrition survey,
and a health examination survey. Data were collected by means
of household interviews and direct standardized physical exam-
inations conducted in mobile examination centers. The 16 ad-
ministrative districts where this survey was performed include
both urban and rural areas. Seoul (the capital city of South Ko-
rea) and the surrounding metropolitan area (Gyeonggi), and six
other metropolitan cities (Busan, Incheon, Gwangju, Daejeon,
Daegu, and Ulsan) of South Korea comprised the urban areas.
The restof the regions (Gangwon,Chungbuk,Chungnam,Gyeo-
ngbuk, Gyeongnam, Jeonbuk, Jeonnam, and Jeju) were rural
areas. Almost all regions of South Korea are located between
33°N and 38°N of latitude; thus, the latitude of area was not
considered in this study. Seasonswere classified as spring (March
to May), summer (June to August), fall (September to Novem-
ber), and winter (December to February). The samples were col-
lected throughout the four seasons as follows: 16.6% in spring,
31.4% in summer, 30.3% in fall, and 21.8% in winter. Also,
there was no gender difference among the seasons in which the
samples were collected.
Among the 16 administrative districts, the 500 survey regions
were drawn from the population and housing census. Based on
the 2005 population and housing census in South Korea, the
sampling frame was made. A stratified, multistage probability
sampling design was used to select household units. For the
KNHANES IV, nationwide stratified sampling was conducted;
thereweremore than 260,000 primary sampling units each year,
and 200 sampling frames fromprimary sampling unitswere ran-
domly sampled. Participants were classified according to age
(child, adult, and elderly), gender, type of housing (apartment,
nonapartment), and residential area (urban, rural), and in each
stratum, survey clusters were selected. Twenty-three households
within a clusterwere sampled using a systemic samplingmethod.
In the second (2008) and third years (2009) of the KNHANES
IV, 25,250 individuals were sampled, and 19,841 subjects par-
ticipated in this survey; the response ratewasabout82%.Among
those who participated in the survey between January 2008 and
December 2009, BMD values were available for 10,730 partic-
ipants: 4796 men and 5934 women. Among them, we selected
4276 participants (mean age 28.96  8.15 yr)—1926 men and
2350 women aged 10–40 yr. The mean age of menarche was
13.26 1.45 yr, and 70.9% of the women had their first period
at ages between 12 and 14. Participants with a history of osteo-
porosis treatment were excluded. Serum 25(OH)D levels were
obtained from all 16 administrative districts of South Korea and
were available for all participants. These participants signed an
informed consent form.
Biochemical analysis
During the survey, blood samples were collected from all par-
ticipants for biochemical analysis. Fasting plasma glucose, total
cholesterol, triglyceride, and high-density lipoprotein (HDL)-cho-
lesterol levels were determined by enzymatic methods using com-
mercially available kits: Pureauto S GLU, Pureauto SCHO-N,
Pureauto STG-N, andCholestestNHDL(Daiichi PureChemicals,
Tokyo, Japan) and a Hitachi Automatic Analyzer 7600 (Hitachi,
Tokyo,Japan). Insulin levelsweremeasuredusingagammacounter
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(1470Wizard; Perkin-Elmer, Turku, Finland) with an immunora-
diometric assay (Biosource, Nivelles, Belgium). The intra- and in-
terassay coefficients of variation were 1.6–2.2 and 6.1–6.5%, re-
spectively. Serum 25(OH)D levels were measured using a gamma
counter (1470Wizard, Perkin-Elmer) with anRIA (DiaSorin, Still-
water,MN). The intra and interassay coefficients of variationwere
2.9–5.5 and6.3–12.9%, respectively.We converted25(OH)D lev-
els to nanomoles per liter, multiplying them by 2.5.
Bone densitometry and geometric analysis
BMD was measured at the left hip in the posteroanterior
projection using dual x-ray absorptiometry equipment
(QDR4500A; Hologic Inc., Waltham, MA) located in mobile
examination centers. As described previously, we further an-
alyzed bone structural properties using the Hip Structure
Analysis program included in the APEX software of Hologic
Inc. Themeasurements by theHip Structure Analysis program
included cross-sectional area (CSA), cross-sectional moment
of inertia (CSMI), buckling ratio, and mean cortical thickness
in each of the narrow neck regions (8).
Statistical analysis
Statistical analyses were conducted using PASWversion 18.0
for Windows (SPSS Inc., Chicago, IL) and SAS version 9.2 (SAS
Institute Inc., Cary, NC). Student’s t test and one-way ANOVA
were used to compare differences in mean values of baseline
parameters among the groups. To investigate differences in skel-
etal andnonskeletal outcomes according to the degree of vitamin
D deficiency, serum 25(OH)D levels were categorized into four
groups: less than 25 nmol/liter, 25 to less than 50 nmol/liter, 50
to less than 75 nmol/liter, and 75 nmol/liter or greater. We used
the group with serum 25(OH)D levels 50 to less than 75 nmol/
TABLE 1. Baseline characteristics
Characteristic Total Men Women
n 4276 1926 2350
Age (yr) 28.96  8.15 28.61  8.34 29.24  7.98
Height (cm) 165.49  9.03 172.26  7.51 159.95  5.82
Body weight (kg) 62.48  13.33 70.16  12.87 56.18  9.98
Waist circumference (cm) 76.75  10.62 80.97  10.28 73.29  9.59
Body mass index (kg/m2) 22.66  3.67 23.55  3.62 21.92  3.56
Systolic blood pressure (mm Hg) 106.13  12.97 112.14  13.34 101.61  10.66
Diastolic blood pressure (mm Hg) 70.56  11.19 75.24  11.47 67.03  9.56
Calcium intake per day (mg) 487.34  313.34 555.86  344.90 438.72  278.92
Current smoker (%) 25.2 46.1 8.1
Regular walking (%)a 46.3 49.5 43.7
Regular exercise (%)b 26.0 29.9 22.9
Serum 25(OH)D (nmol/liter) 44.15  15.65 47.05  16.65 41.80  14.35
25 nmol/liter (%) 18.8 14.2 22.6
25 to 50 nmol/liter (%) 50.0 48.0 51.6
50 to 75 nmol/liter (%) 27.0 31.5 23.3
75 nmol/liter (%) 4.2 6.3 2.5
Fasting glucose (mg/dl) 90.69  13.93 91.82  14.00 89.76  13.81
Insulin (IU/ml) 10.30  5.56 10.71  6.43 9.96  4.70
HOMA-IRc 2.34  1.50 2.47  1.76 2.23  1.22
Total cholesterol (mg/dl) 173.68  31.85 177.57  34.39 170.48  29.23
HDL-cholesterol (mg/dl) 53.82  12.20 50.01  10.94 56.95  12.29
Triglyceride (mg/dl) 110.93  96.13 139.32  117.59 87.67  65.45
LDL-cholesterol (mg/dl) 105.09  28.33 109.36  26.92 100.64  29.10
Total alkaline phosphatase (U/liter) 272.18  211.95 321.56  247.69 230.28  164.88
Serum creatinine (mg/dl) 0.89  0.29 1.04  027 077  0.25
Lumbar spine (g/cm2) 0.97  0.13 0.97  0.14 0.97  0.13
Femur trochanter (g/cm2) 0.67  0.09 0.70  0.09 0.65  0.08
Femoral neck (g/cm2) 0.81  0.13 0.87  0.13 0.77  0.11
Femur total (g/cm2) 0.94  0.13 1.00  0.13 0.90  0.11
FN cortical thickness (mm) 1.90  0.31 2.00  0.33 1.80  0.26
FN CSA (cm2) 3.13  0.62 3.54  0.60 2.80  0.41
FN CSMI (cm4) 3.00  1.09 3.83  0.99 2.32  0.56
FN buckling ratio 9.68  2.00 9.83  2.06 9.55  1.93
Data are expressed as mean  SD, unless indicated otherwise. All analyses presented here include data of a random subgroup of participants.
Blood pressure data were available for 1248 participants, calcium intake per day for 3631 participants, total alkaline phosphatase for 3028
participants, serum creatinine for 1248 participants, and LDL-cholesterol for 827 participants. BMD was available for 4258, and geometric index
was available for 2876 participants. LDL, Low-density lipoprotein; FN, femur neck.
a Regular walking was defined as more than a 30-min walk for more than five times per week, regardless of indoor or outdoor walking.
b Regular exercise was defined as moderate or severe exercise on a regular basis, regardless of indoor or outdoor exercise (more than 30 min at a
time and more than five times per week in case of moderate exercise such as swimming slowly, tennis doubles, volleyball, badminton, table tennis,
and carrying light objects; more than 20 min at a time and more than three times a week in case of severe exercise such as running, climbing,
cycling fast, swimming fast, football, basketball, jump rope, squash, tennis singles, and carrying heavy objects).
c HOMA-IR was calculated with insulin and fasting glucose level as: fasting glucose (milligrams per deciliter)  insulin (IU per milliliter)/405.
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liter as the reference group. Spline plots with 95% confidence
intervals and analysis of covariance, adjusted for possible con-
founding factors, such as age, body mass index, season, regular
walking, and regular exercise, were performed to examine the
relationship between serum 25(OH)D level and BMD. The cri-
teria for season, regular walking, and regular exercise were the
same as described by Choi et al. (6). The association between
serum 25(OH)D itself and each BMD was determined by Pear-
son’s correlation coefficient. Multivariate logistic regression
analyseswere used to examine odds ratio of concomitant disease
between groupswith 25(OH)D less than 50 and at least 50 nmol/
liter, adjusted for age, sex, bodymass index, and seasons. The 2
test was used to inquire into the prevalence of concomitant dis-
eases according to serum 25(OH)D levels. P values0.05 were
considered statistically significant.
Role of the funding source
The sponsor of the study had no role in study design, data
collection, data analysis, data interpretation, or writing of the
report. The corresponding author had full access to all the data
in the studyandhad final responsibility for thedecision to submit
for publication.
Results
The baseline characteristics of all the participants are pre-
sented in Table 1. The average age was 28.61 8.34 yr in
men and 29.24  7.98 yr in women. As previously re-
ported, in the younger generation, vitamin D deficiency
wasmore frequent inwomen than inmen. Themean value
of serum 25(OH)D was 47.05 16.65 nmol/liter in men
and41.8014.35nmol/liter inwomen.Moreover, serum
25(OH)Dwas less than25nmol/liter in18.8%of subjects,
25 to less than 50 nmol/liter in 50.0%, 50 to less than 75
nmol/liter in 27.0%, and 75 nmol/liter or greater in 4.2%.
Both total body fatmass andpercentagewere significantly
FIG. 1. BMD (A and B) and serum 25(OH)D (C and D) in young generation. In both sexes, BMD showed a “spooning pattern” with age (A and B).
Based on the age-specific changes in BMD, the participants were divided into three age groups per gender: 10–22, 23–29, and 30–40 yr in men;
and 10–19, 20–28, and 29–40 yr in women. Vitamin D deficiency was most frequent in young people (C). The phases were named the modeling
phase, decelerating phase, and consolidating phase, respectively (D). The change in mean 25(OH)D level according to phase was similar to that of
BMD. *, P  0.001, compared with the modeling phase; §, P  0.001, compared with the decelerating phase.
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higher in women, whereas BMD and geometric indices
were significantly higher in men, except for lumbar spine
BMD.
Age-related changes in BMD and serum 25(OH)D
Figure 1 demonstrates changes in BMD andmean serum
25(OH)D according to age. Interestingly, in both sexes, a
“spooningpattern”of total hipBMDwithagewas shown in
Fig. 1, A and B. In youngmen, BMD increased from age 10,
reaching its highest level at age 22, then decreased, reaching
its lowest level at age 29, after which it remained relatively
constant until age 40. For young women, BMD changes
showed similar trends, but a peakoccurred at age 19 and the
minimumat age 28. Based on these age-specific findings, we
dividedtheparticipants intothreeagegroups:10–22,23–29,
and 30–40 yr in men, and 10–19, 20–28, 29–40 yr in
women. The phases were named the modeling phase, de-
celerating phase, and consolidating
phase, respectively. As shown in Fig.
1C, vitamin D deficiency was most
frequent in the younger generation.
Moreover, serum 25(OH)D, which
had the lowest mean level in the de-
celerating phase, presented similar
patterns in both sexes according to
phase (Fig. 1D).
Skeletal effects of vitamin D
As shown in Fig. 2A, in young men,
there was no linear relationship between
BMD change and serum 25(OH)D level
in themodeling phase, afterwhich femur
neck BMD had a positive correlation
with serum 25(OH)D (R  0.14, P 
0.002 in the decelerating phase; R 
0.10, P  0.003 in the consolidating
phase). In women 20 yr or older, there
was a weak positive correlation between
femur neck BMD and serum 25(OH)D
level (R 0.08, P 0.04 in the deceler-
ating phase; R  0.06, P  0.03 in the
consolidating phase); however, there
seemed tobeanegative association in the
modelingphase (R0.17;P0.002).
In both sexes, these tendencies in femur
neck BMD were similar to that in the
lumbar spine BMD (Fig. 2B).
We further analyzed the mean BMD
values in each group according to serum
25(OH)D level to evaluate the signifi-
cance of the results obtained from the
spline plots. Intriguingly, therewere gen-
der differences in the skeletal effects of
vitamin D (Table 2). In males aged 10–22 yr, BMD was
significantly higher in the group with 25(OH)D levels of at
least 75 nmol/liter than in the reference 50–75 nmol/liter
group; on the other hand, BMD in men aged 23 yr or older
was significantly lower in the vitamin D-deficient group. In
youngwomen, therewere no significant differences in BMD
according to 25(OH)D. Also, no meaningful results were
observed foranygeometric indicesexcept femurneckCSAin
men(Table2andSupplementalTables1and2,publishedon
The Endocrine Society’s Journals Online web site at http://
jcem.endojournals.org).
Nonskeletal effects of vitamin D
Anthropometric characteristics, biochemical parame-
ters, and metabolic profiles including HOMA-IR accord-
ing to serum 25(OH)D level are presented in Table 3.
FIG. 2. Correlation between BMD and serum 25(OH)D according to three phases. For each
phase, the BMD change () of the femur neck (A) and lumbar spine (B) varied according to
the level of 25(OH)D. BMD (g/m2) change () on the y-axis was compared with the mean
BMD value (0.0) of each phase. Dotted lines represent 95% confidence intervals.
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Although mean 25(OH)D levels were significantly differ-
ent between groups, most nonskeletal parameters were
not associated with 25(OH)D level in men. Plasma tri-
glyceride level showed a significant P value; however, the
intergroup differences were not definite. In women, no
significant parameters were observed. Figure 3 lists the
odds ratio of concomitant diseases according to serum
25(OH)D level. Comparedwith the groupwith 25(OH)D
levels greater than50nmol/liter, therewere no statistically
significant odds ratios in the less than 50 nmol/liter group.
Although rheumatoid arthritis was more prevalent in the
vitaminD-deficient group, theprevalenceof othermedical
conditions was not associated with the concentration of
serum 25(OH)D (Supplemental Table 3).
Discussion
Recently, the significance of vitamin D has been empha-
sized in public health contexts because vitamin D defi-
ciency, which is independently associated with an in-
creased risk of mortality in the general population (9), is
TABLE 2. BMD and geometric index according to serum 25(OH)D level
Serum 25(OH)D (nmol/liter)
F P value<25 25 to <50 50 to <75 >75
BMD (g/cm2)a
Men
10–22 yr oldb n  71 n  234 n  135 n  17
Lumbar spine 0.88  0.15 0.88  0.14 0.86  0.19 0.97  0.19** 4.59 0.004
Femoral neck 0.86  0.15 0.87  0.14 0.86  0.16 0.96  0.16* 4.75 0.003
Total hip 0.95  0.15 0.97  0.14 0.96  0.15 1.06  0.16** 5.91 0.001
23–29 yr old n  86 n  225 n  123 n  14
Lumbar spine 1.00  0.10 0.99  0.12 1.02  0.12 1.02  0.12 2.23 0.084
Femoral neck 0.90  0.13 0.89  0.13** 0.94  0.14 0.98  0.14 5.08 0.002
Total hip 1.02  0.11 1.01  0.12** 1.05  0.13 1.05  0.11 4.01 0.008
30–40 yr old n  106 n  406 n  301 n  74
Lumbar spine 0.96  0.11** 0.99  0.12 1.01  0.12 1.00  0.11 4.22 0.006
Femoral neck 0.82  0.12** 0.85  0.12 0.87  0.11 0.85  0.13 3.74 0.011
Total hip 0.95  0.12*** 1.00  0.12 1.02  0.12 1.01  0.12 6.53 0.001
Geometric indexc
FN cortical thickness (mm) 2.00  0.41 2.00  0.35 2.00  0.29 2.00  0.36 1.50 0.214
FN CSA (cm2) 2.56  0.64 3.59  0.56 3.62  0.53 3.61  0.61 2.96 0.032
FN CSMI (cm4) 3.92  0.86 3.98  0.89 4.05  0.86 4.02  0.87 2.26 0.080
FN buckling ratio 10.27  2.47 9.96  2.05 9.94  1.97 9.96  2.21 2.51 0.057
Women
10–19 yr oldb n  57 n  172 n  87 n  7
Lumbar spine 0.92  0.13 0.87  0.14 0.84  0.15 0.77  0.15 0.94 0.421
Femoral neck 0.79  0.13 0.75  0.12 0.73  0.12 0.68  0.14 0.49 0.693
Total hip 0.91  0.13 0.88  0.12 0.86  0.13 0.80  0.14 1.11 0.344
20–28 yr n  169 n  320 n  95 n  13
Lumbar spine 0.96  0.11 0.96  0.10 0.97  0.11 0.98  0.13 0.33 0.805
Femoral neck 0.77  0.10 0.78  0.10 0.79  0.11 0.79  0.12 1.99 0.115
Total hip 0.88  0.11 0.90  0.10 0.91  0.11 0.91  0.12 1.49 0.216
29–40 yr n  270 n  627 n  325 n  37
Lumbar spine 0.99  0.11 1.00  0.11 1.01  0.12 1.00  0.10 0.44 0.728
Femoral neck 0.76  0.10 0.76  0.10 0.77  0.11 0.79  0.10 1.41 0.237
Total hip 0.89  0.11 0.90  0.11 0.91  0.11 0.93  0.11 1.58 0.193
Geometric indexc
FN cortical thickness (mm) 1.80  0.26 1.80  0.27 1.80  0.26 1.80  0.30 0.10 0.958
FN CSA (cm2) 2.79  0.36 2.82  0.38 2.86  0.41 2.87  0.42 0.84 0.471
FN CSMI (cm4) 2.32  0.49 2.37  0.55 2.42  0.58 2.43  0.52 0.36 0.784
FN buckling ratio 9.64  1.96 9.68  1.94 9.57  1.97 9.47  1.91 0.75 0.525
Data are expressed as mean  SE. Geometric indices were available for 2876 participants. Season of vitamin D determination was defined four
periods during the year: March to May, June to August, September to November, and December to February. Overall results were derived from the
covariance analysis. FN, Femur neck.
a BMD was adjusted for age, body mass index, regular walking, regular exercise, and season, except men aged 10–22 yr and women aged
10–19 yr.
b In men aged 10–22 yr and women aged 10–19 yr, BMD was adjusted for age, body mass index, and season.
c Geometric index was adjusted for age, body mass index, regular walking, regular exercise, and season.
* P  0.05; ** P  0.01; *** P  0.001, for comparison with the reference group with serum 25(OH)D of 50 to 75 nmol /liter.
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a great threat to both young and elderly people (1, 6, 10–
12). Previous studies have reported that vitamin D defi-
ciency is related toahigher riskofmetabolicbonediseases,
cancers, autoimmune diseases, infection, diabetes melli-
tus, and cardiovascular disease (2, 13–19). Moreover, in
children, vitamin D deficiencymay increase adiposity and
lower HDL cholesterol (20), and vitamin D supplemen-
tation can prevent asthma exacerbation caused by acute
respiratory infection (21). However, there is a paucity of
systemic data on the skeletal and nonskeletal effects of
vitamin D deficiency in the youth.
In this study, the acquisition of PBM was achieved in
women at the end of adolescence, and was delayed several
years in men, as previously reported (5). Intriguingly, we
observed a “spooning pattern” in femur neck and total hip
BMD, indicating that after reaching PBM, BMD decreased
TABLE 3. Nonskeletal characteristics of each group according to serum 25(OH)D level
Serum 25(OH)D (nmol/liter)
P value<25 25 to <50 50 to <75 >75
Men (n) 273 925 606 122
Anthropometric parameters with agea
Age (yr) 27.09  7.69 28.24  8.20 29.25  8.74 31.68  7.69 0.001
Height (cm) 172.48  7.07 172.78  7.16 171.34  8.24 172.36  6.89 0.003
Body weight (kg) 68.76  12.46 70.60  13.15 70.27  13.05 69.41  10.45 0.192
Waist circumference (cm) 79.77  10.41 80.99  10.41 81.52  10.26 80.81  8.86 0.137
Body mass index (kg/m2) 23.06  3.71 23.55  3.67 23.82  3.62 23.31  2.90 0.031
Cardiopulmonary parameters
Systolic blood pressure (mm Hg)a 110.81  13.45 112.13  13.79 112.26  13.70 112.54  10.96 0.917
Diastolic blood pressure (mm Hg)a 75.07  11.92 75.28  12.47 75.60  11.15 74.16  9.43 0.829
FEV1/FVC (%)b 0.86  0.05 0.83  0.07 0.83  0.06 0.82  0.07 0.184
Bone metabolic parameters
Serum 25(OH)D (nmol/liter)a 24.98  3.55 39.90  5.48 60.15  6.99 85.40  8.69 0.001
Calcium intake per day (mg)a 530.11  353.12 538.49  317.53 589.54  366.34 571.06  395.06 0.050
Total ALP (U/liter)c 230.43  61.22 230.38  58.05 224.14  54.59 219.36  59.48 0.362
Metabolic parametersc
Fasting glucose (mg/dl) 91.09  16.51 91.35  10.97 93.19  18.92 91.05  7.59 0.388
Insulin (IU/ml) 9.95  4.51 10.64  7.09 9.92  4.71 9.20  3.88 0.080
HOMA-IR 2.26  1.17 2.46  2.01 2.32  1.37 2.09  0.96 0.196
Total cholesterol (mg/dl) 177.65  32.79 181.12  34.55 182.64  31.68 180.97  29.27 0.820
HDL-cholesterol (mg/dl) 50.25  10.81 49.92  11.10 49.79  11.19 49.19  10.56 0.582
Triglyceride (mg/dl) 138.89  119.55 151.67  132.87 145.40  113.77 127.38  80.89 0.039
Women (n) 531 1212 548 59
Anthropometric parameters with agea
Age (yr) 29.22  7.40 28.98  7.99 29.77  8.50 29.88  7.71 0.252
Height (cm) 160.31  5.48 160.06  5.83 159.35  6.02 160.09  6.33 0.038
Body weight (kg) 55.73  9.45 56.44  9.94 55.95  10.51 56.82  10.56 0.489
Waist circumference (cm) 72.28  9.06 73.42  9.53 73.79  9.97 75.09  11.13 0.021
Body mass index (kg/m2) 21.67  3.44 22.00  3.52 21.98  3.70 22.16  3.97 0.312
Cardiopulmonary parameters
Systolic blood pressure (mm Hg)a 101.38  10.91 101.22  10.53 102.13  10.85 103.04  9.44 0.675
Diastolic blood pressure (mm Hg)a 66.94  9.82 67.24  9.41 66.61  9.73 68.37  9.11 0.765
FEV1/FVC (%)b 0.85  0.07 0.83  0.09 0.83  0.07 0.84  0.06 0.234
Bone metabolic parameters
Serum 25(OH)D (nmol/liter)a 25.23  3.61 39.28  5.44 59.10  6.70 81.85  7.64 0.001
Calcium intake per day (mg)a 431.22  289.76 441.07  281.32 435.80  262.81 484.60  283.58 0.586
Total ALP (U/liter)c 185.11  52.93 186.38  55.41 189.26  61.99 180.85  45.65 0.689
Metabolic parametersc
Fasting glucose (mg/dl) 88.75  9.86 89.91  13.44 90.61  18.13 89.75  8.83 0.861
Insulin (IU/ml) 9.40  5.00 9.60  4.23 9.27  3.45 9.20  3.73 0.510
HOMA-IR 2.09  1.32 2.15  1.13 2.10  1.07 2.07  0.94 0.675
Total cholesterol (mg/dl) 166.76  29.30 172.17  29.92 174.03  28.03 172.49  25.88 0.050
HDL-cholesterol (mg/dl) 57.07  12.88 57.62  12.42 57.07  12.35 54.86  11.55 0.166
Triglyceride (mg/dl) 84.03  56.11 87.92  65.21 86.28  53.30 83.76  50.43 0.757
Data are expressed as mean  SE. ANCOVA, adjusted for age, body mass index, season, regular walking, and regular exercise, was used. FEV1,
forced expiratory volume in 1 second; FVC, forced vital capacity; ALP, alkaline phosphatase.
a Variables were derived from ANOVA.
b FEV1/FVC (%) data were available for 289 men and 338 women.
c Reference ranges: total ALP, 38.0–115.0 U/liter; fasting glucose, 70–110 mg/dl; insulin, 4.2–5.0 IU/ml; total cholesterol, 100–220 mg/dl;
HDL-cholesterol, 40–400 mg/dl; triglyceride, 44–166 mg/dl.
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rapidly until the age of 28 or 29, then slightly increased or
remained constant. This phenomenon appeared to be more
prevalent inwomenthaninmen.Khoslaetal. (22)previously
mentioned such a spooning pattern at the distal radius and
distal tibia using peripheral quantitative computed tomog-
raphy, but this change was only found in young adult men.
They suggested that it could be associated with hormonal
changes such as declining serum IGF-I levels (22). In our
study, changes in serum 25(OH)D with age were similar to
that of BMD. Therefore, we hypothesized that vitamin D
status is one of the major determinants in the spooning pat-
tern of BMD in young adults and aimed to assess the rela-
tionship between vitamin D deficiency and BMD in this
population.
Interestingly, therewere gender differences in the skeletal
effects of vitamin D in three phases. In young men, BMD in
the modeling phase was higher in the vitamin D-sufficient
group, but no linear relationship was found in spline plots,
suggesting that multiple factors other than vitamin D may
contribute to bone health during this phase. Although the
Pearson correlation coefficient was low, BMD in the decel-
erating and consolidating phases had a positive correlation
with 25(OH)D level and may be relatively more susceptible
to vitaminDdeficiency than that in themodeling phase. For
youngwomen, contrary to expectations, nomeaningful dif-
ferences in both BMD and geometric indices according to
25(OH)D level were observed in each of the three phases,
although the prevalence of vitamin D deficiency was higher
inwomenthaninmen.Thenextquestionwashowtoexplain
such gender differences.
According to the “unitary model” proposed by Riggs
andMelton, estrogen deficiency is the predominant cause
of both early, accelerated and late, slow phases of bone
loss in postmenopausal women and is a
contributing cause of the continuous
phase of bone loss in aging men (23,
24). In both genders, there is a steady
decline in bioavailable estrogen level
with age, although the absolute value is
different, superimposed on which is a
marked decrease in estrogen level in
women at menopause (25). Even in el-
derly men, estrogen is more important
than androgen, and the yearly incidence
of fractures increased remarkably at es-
tradiol levels of less than 16 pg/ml (26).
Estrogen directly or indirectly stimulates
intestinal calcium absorption by enhanc-
ing expression of vitamin D receptors
(VDR)or calbindinD in themucosa, and
also stimulates 1-hydroxylase activity
in the kidneys (27). This study showed
the possibility that estrogen has a major
influence on BMD starting just after the formation of PBM,
rather than after menopause. The gender differences in the
skeletal effects of vitamin D might be attributed to some
protective roles of estrogen that surpass the disadvantage of
vitamin D deficiency commonly observed in young women.
Sclerostin, the secreted Wnt antagonist produced by
osteocytes, regulates bone mass negatively by binding to
low-density lipoprotein receptor-related protein 5 and 6
(28). PTH may suppress the expression of sclerostin
through myocyte enhancer factor-2 transcription factors
(29). Estrogen also decreases circulating sclerostin level,
but not testosterone (28). Thus, elevated PTH caused by
vitamin D deficiency and estrogen might synergistically
decrease sclerostin. Meanwhile, we do not yet know
whether the decelerating phase comes from accelerated
bone resorptionor inadequate bone formation. Ethnic dif-
ferences should be considered to understand this interest-
ing observation, andmore research is neededon the effects
of sex hormone or calciotropic hormone on sclerostin and
the alteration of GH-IGF secretion patterns in both
genders.
Regarding the nonskeletal effects of vitamin D, there
were no differences in metabolic profiles, such as insulin
resistance and lipids, or cardiopulmonary parameters in
the three phases, except for plasma triglycerides inmen. In
our unpublished study, which looked at all ages of the
general population, basal insulin level and HOMA-IR
were elevated in the vitaminD-deficient group.There is no
good explanation for this discrepancy, but we speculated
that insulin resistance may be aggravated by vitamin D
deficiency in elderly people who have a limited reserve
capacity of -cells. VDR is also expressed in -cells, and
FIG. 3. Odds ratios (95% confidence interval) of concomitant diseases according to serum
25(OH)D level. Multivariate logistic regression analyses were used to examine the odds ratios
of concomitant diseases between groups with 25(OH)D less than 50 and at least 50 nmol/
liter, adjusted for age, sex, body mass index, and season. COPD, Chronic obstructive
pulmonary disease; OR, odds ratio; CI, confidence interval.
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VDR expression has been thought to be a determinant of
insulin secretory capacity (30). In an association study,
only rheumatoid arthritis seemed to be more prevalent in
the vitamin D-deficient group. However, further study is
needed to examine the relationship between 25(OH)D
level and concomitant diseases in this age group because
the number of participants with underlying disease was
insufficient to confirm the significance of this content.
The major strength of this study is that we analyzed data
collected from a nationwide survey including more than
4000participants aged 40or younger inKorea,which is one
of the most vitamin D deficiency-prone countries among
young people (6). This is the first observational study to in-
vestigate skeletalandnonskeletalhealth extensively accord-
ing to vitamin D status, focusing on the younger genera-
tion. However, this study also has some limitations. First,
data were obtained from a questionnaire. Second, al-
though occupational factor also could affect serum
25(OH)D level (6), we did not use occupation as an ad-
justment factor because more than 40% of all the partic-
ipants were students or housewives, and those who
worked outdoors only comprised 0.5% of the subjects
20–30 yr old. Third, we could not distinguish the age-
related changes in trabecular bone from cortical bone due
to the limitation of dual x-ray absorptiometry. Fourth, the
relationship between serum25(OH)DandPTH levelswas
not assessed. Lastly, we could not inquire into data re-
garding physical activity in the modeling phase, which
might affect young people’s vitamin D status. Hence, it is
statistically probable that there were small significant dif-
ferences, comparedwithmost studies targeting the elderly.
However, because the survey proceeded in detail, showing
the prospective nature, our results are very reliable.
Vitamin D plays an important role in skeletal he-
alth of young people. Thus, serum 25(OH)D level
should be maintained at 20–30 ng/ml or higher, espe-
cially during the modeling phase in men, to ensure
BMD. We have little evidence to support the necessity
of higher doses of vitamin D supplementation to main-
tain a serum 25(OH)D level of higher than 30 ng/ml
consistently in this age group. In addition, young people
tend to have indoor activities compared with other age
groups (6). Therefore, we should not overlook the impor-
tance of lifestyle modification to encourage the younger
generation to be adequately exposed to sunlight in a va-
riety of ways, including regular use of a tanning bed (31).
Further study is necessary to examine the gender-depen-
dent skeletal effects of vitamin D in younger generations.
Our results would be very helpful and informative to phy-
sicians and public healthcare officials.
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